Not applicableStudy completedNCT04101565What this trial is testingText4Father Pilot Feasibility, Acceptability StudyWho this might be right forFathersMhealthMobile Health+1 more Johns Hopkins University 120
Not applicableLooking for participantsNCT06289101What this trial is testingText4FATHER R21: Social Media - Efficacy TrialWho this might be right forFathersMobile HealthNuclear Family Johns Hopkins University 180
Not applicableLooking for participantsNCT07336394What this trial is testingPrecision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance TechniquesWho this might be right forDanon DiseaseFabry DiseaseCardiac Amyloidosis+4 more Chinese Academy of Medical Sciences, Fuwai Hospital 1,000
Not applicableStudy completedNCT00005914What this trial is testingGenetics of Recurrent Early-Onset DepressionWho this might be right forDepression Stanford University 2,533
Not applicableNot Yet RecruitingNCT07412028What this trial is testingIdentification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)Who this might be right forPolycystic Ovary SyndromeFamilial Partial LipodystrophyLMNA (LaMin Nuclear A) Related Disorders Assistance Publique - Hôpitaux de Paris 81
Not applicableLooking for participantsNCT06065852What this trial is testingNational Registry of Rare Kidney DiseasesWho this might be right forAdenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more UK Kidney Association 35,000
Not applicableStudy completedNCT03812172What this trial is testingScreening for Cardiac Amyloidosis With Nuclear Imaging for Minority PopulationsWho this might be right forAmyloid Cardiomyopathy, Transthyretin-Related Mathew S. Maurer, MD 646
Testing effectiveness (Phase 2)Study completedNCT00117819What this trial is testingBrain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's DiseaseWho this might be right forParkinsonian Syndrome Institute for Neurodegenerative Disorders 232